Analytical Data
-
Gene name
CNPY4
- Application
-
Alternative Names
CNPY4;Protein canopy homolog 4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N129
-
Expression Region
22-248aa
-
AA Sequence
GMLKEEDDD TERLPSKCEV CKLLSTELQA ELSRTGRSRE VLELGQVLDT GKRKRHVPYS VSETRLEEAL ENLCERILDY SVHAERKGSL RYAKGQSQTM ATLKGLVQKG VKVDLGIPLE LWDEPSVEVT YLKKQCETML EEFEDIVGDW YFHHQEQPLQ NFLCEGHVLP AAETACLQET WTGKEITDGE EKTEGEEEQE EEEEEEEEEG GDKMTKTGSH PKLDREDL
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CNPY4, a member of the CNPY protein family, has garnered attention in recent years due to its potential roles in various biological processes and its implications in disease mechanisms. Initially identified as a protein associated with the endoplasmic reticulum, CNPY4 is involved in cellular functions such as stress response, signaling pathways, and protein folding. Studies have suggested that CNPY4 may play a significant role in the regulation of metabolic pathways and is thought to be linked to diseases such as cancer and neurodegenerative disorders. Research into the recombinant form of CNPY4 has aimed to elucidate its structure-function relationships, with a focus on understanding how alterations in its expression might contribute to pathophysiological conditions. The production of recombinant CNPY4 has allowed scientists to explore its biochemical properties and interactions within cellular environments, contributing to a deeper understanding of its physiological roles. Additionally, the development of CNPY4 as a potential biomarker or therapeutic target is an area of ongoing investigation, with the hope that insights gained from these studies could lead to novel strategies for treating diseases associated with CNPY4 dysregulation. Understanding the molecular mechanisms underlying CNPY4’s function will not only advance our knowledge of cellular biology but also pave the way for targeted therapeutic interventions in related diseases.
